Summary of Purpose
Anticoagulants are generally recognized as a necessary therapy to prevent the recurrence of ischemic stroke in patients with non-valvular atrial fibrillation (NVAF), but in some patients they also cause bleedings, particularly intracranial hemorrhage. One of the independent predictors of intracerebral hemorrhage is the presence of cerebral microbleeds (CMBs); a high incidence of intracerebral hemorrhage is...Read More →
The following dates are available for this trial. Trial information last updated on 18 October 2016.
|1 Mar 2015||1 Feb 2015||1 Sep 2016||1 Sep 2017||1 Oct 2016||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Observation: Cohort
- Perspective: Prospective
- Sampling: Non-Probability Sample